Mobile

Better Accepance of a Singe injection Apidra (insulin glulisine) Added to once daily Lantus (insulin glargine) versus twice daily Premixed insulin in a real Life Use Setting

Update Il y a 4 ans
Reference: EUCTR2009-015742-34

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To demonstrate non-inferiority of once daily injection of insuline glargine (Lantus®) plus one injection of mealtime insulin glulisine (Apidra®) at the main meal versus twice daily premixed insulin (NovoMix® 30/70) based on the reduction of HbA1c percentage from baseline to endpoint.

Inclusion criteria

  • Type 2 diabetes mellitus

Links